Reddit Posts
FULL Nasdaq Article by Ari Zoldan: How Three Companies Are Taking Aim at Alleged Naked Short Sellers - 28 Nov 2023 - (immortalized in photos + links)
NRXP FDA provided Written Responses on January 10 th. As previously announced in October 2022 , an updated NRX-101 module 3 was submitted to add the intended commercial manufacturer to the IND. With FDA's written response, it appears that NRx Pharmaceuticals has reached alignment with the FDA
BREZ has the best risk/reward for SPACs since CCIV in 2021 at $12, low float with huge call OI for May + gamma squeeze potential
It’s criminal for Fauci to delay approval of Zyesami from $NRXP and $RLFTF. Now Ted Cruz is all over it to make sure it happens…link below. This needs to be all over Fox News, joe Rogan, etc ASAP
Senator Ted Cruz pressing Fauci for why RLFTF (relief) and NRXP’s Zyesami hasn’t gotten eua yet and is saving lives from covid!!!!. Guys you need to see this. This needs fo be blasted ALL over the news. This is criminal what the FDA does. PLEASE READ the link below. CONGRESS is all over this!!!!
NRXP, 673K shares bought by someone, Zyesmi works for COVID patients
NRXP Short Volume 55%, Is it setting up for a squeeze?
NRx Receives Initial Report of Patient Safety and Survival from Right to Try use of ZYESAMI® (aviptadil) during Omicron Surge
NRx Pharmaceuticals (NRXP) CEO to Provide Business Update on January 10th
Relief Therapeutics (RLF.SW, RLFTF) Is flying again today, NRXP will follow too.
Proud holding Relief Therapeutics (RLF.SW, RLFTF) & NRXP! https://miamicourant.com/stories/617928153-op-ed-the-emergency-use-law-should-be-used-for-emergencies-like-now
Relief Therapeutics (RLF.SW, RLFTF) flying today 46% and more to come🤞, NRXP just released a PR for a new EUA submission. With this one approved both of them will have a huge run!
NRXP Stock Rumbles On Request For Therapy Designation.
NRXP NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil)
NRXP 0 shares available, has filled gap back down after its covid variant vaccine PR. Said they will be testing on new variant
$NRXP Zyesemi and BriLife is the Covid19 game changer. Don’t miss on this one (like I almost missed LGVN).
Play for tomorrow is BMTX and NRXP 🚀🚀🎉🎉🎰🎰 Don’t miss this one out!!
NRXP- held up nicely today as still 23% up from Friday close
NRXP Covid Vaccine don't sleep on it, I see it squeezing back to high 9s 😉💥
CONFUSED! NRXP Study looks towards EUA but price still falling? Any Medical People know why?
NRXP Stock: Aviptadil Effective In Increasing COVID Recovery Odds & Surv...
$NRXP is the play, 23M float, 4.5% short of float (Finviz).
NRXP NEWS Out! Low float, FDA Pending Up Pre-Market!
NRXP 💥 💥 Great PR today, this can go easily to 100$ 🚀 🚀
NRXP - the covid vaccine that may be able to evolve to combat different variants
NRXP anyone, 50% today was even at 80% intraday? Vaccine for Covid plus a potential therapeutic Zyesami/aviptadil (currently in NIH trial h2h with Remdesivir). Good news today from their vaccine trials and seems that this beauty can run fast 💥 💥
NRXP 52W High was 76$ it's currently sitting at 7$, this is a no brainer with Covid Variant all over the news 😉💥
NRXP Stock: Vaccine May Be Capable Of Evolving To Counter Variants. NRX ...
NRXP looks very good, new COVID vacine trail phase 2
NRXP Delta Covid News excellent entry on pullback 💥 Should see 10+
New guy here. Tell me about NRXP. Low float, high short volume and FDA pending drug. Is this a buy? Thanks!
What do an US General, a Professor of Medicine, Head of Mossad, Erectile Dysfunction, and Short Hedge Funds have in common? - The answer may surprise you. (Story of NRX Pharmaceuticals, NRXP)
What do an US General, a Professor of Medicine, Head of Mossad, Erectile Dysfunction, and Short Hedge Funds have in common? - The answer may surprise you. (Story of NRX Pharmaceuticals, NRXP)
What do an US General, a Professor of Medicine, Head of Mossad, Erectile Dysfunction, and Short Hedge Funds have in common? - Story of NRXP
#premarket #watchlist 10/14 $GRVI - Grove, Inc. Launches Amazon Aggregation Division , $NRXP - NRx Pharmaceuticals Announces Progress on Worldwide Commercial Scale Development of ZYESAMI™ , $TSRI -Reports Record Revenue for the First Quar... Any trading ideas? Welcome in comments!
NRXP has a bit of a double bottom happening today Potential for a 10% spike by close
NRXP Full DD: Big mover (up 61% yesterday) and ridiculously cheap stock
Bio stocks - how to not get burnt ?
$NRXP cost to borrow 194%+ - potential FDA approval and covid treatment in the pipe… rack em up
Thoughts on NRXP? Saw their borrow rate at 130% only 10k shares left to borrow?
BYSI and NRXP still my main biotech plays. BYSI lung cancer drug / NRXP COVID therapeutic
Mentions
Thoughts on NRXP?, Just bought some more pre-market stocks, and the minute my order went through, It went down into the negative for me, I'm hopeful that it'll go back up, but not 100% confident atm
$NRXP looking good already LFG 🚀🚀🚀
Ok - the new week is here ! Let’s climb ! 🚀 NRXP - NVNI - CGTX - BTAI - PSTV - THTX
Can’t wait for Monday and this week ! NRXP - NVNI - CGTX - PSTV - BTAI - THTX - 🚀
CGTX - NRXP - NVNI - BTAI - THTX - PSTV This week is going to 🚀to the 🌞
I’m agreeing with everyone here - penny stocks are so risky - yes you can make a lot of money, but also risk to lose your money - If you really feel this is the easiest or quickest way to earn money seeing you have a lot going on in life (your job, family and taking care of your kid, stress financially etc) I would say invest in the following - NRXP - BTAI - NVNI - CGTX - THTX Make sure you pay close attention to these this week, and know to SELL before news or results comes out - just try to make money off the hype PRE NEWS - I wish you and your family the very best
Alright so for next week I’m eyeing these: ENVL sell before or after results tomorrow at 8am. THTX plan on selling after results the 21st. BTAI I’m debating buying and NRXP plan on dumping $5k and holding for a while? What are your thoughts
So are $IXHL, $NRXP, $UNH, $KO, $CVX, $GIBO, $ORIS, and dozens of others. But again your argument is compelling.
I see a lot of $NRXP comments and just be cautious of the $150M shelf registration. I’m in $TNFA instead. https://www.sec.gov/Archives/edgar/data/1719406/000143774925020924/nrxp20250617_s3.htm $150,000,000 COMMON STOCK PREFERRED STOCK DEBT SECURITIES DEPOSITARY SHARES WARRANTS RIGHTS PURCHASE CONTRACTS UNITS From time to time, we may offer and sell, in one or more offerings, up to $150 million of our common stock, par value $0.001 per share (the “Common Stock”), shares of our preferred stock, debt securities, depositary shares, warrants, rights, purchase contracts or units, or any combination thereof. We may also offer securities as may be issuable upon conversion, repurchase, exchange or exercise of any securities registered hereunder, including any applicable anti-dilution provisions.
Onboard for NRXP and THTX and I’m watch SCLX
$NRXP can’t wait for next week!
Been saying this everywhere but MBOT and NRXP is easy money!
Hoping all are having a great weekend - CGTX - NVNI - NRXP - PSTV - BTAI - THTX - AERT - These are all going to climb - up and up! 🚀 Let’s not miss out, and let’s earn together!
PGEN and NRXP are a must watch, plus ELTP can test new highs if it follows the same pattern as the last 2 years.
These are going to climb - 🚀 Make sure to get in for an ride up, up and away! CGTX - NVNI - PSTV - NRXP - BYAI - THTX - IXHL -
I really appreciate the detailed response regarding UNCY, but unfortunately I did mean NRXP. Please see the attached link to NRXP’s most recent SEC filings. [https://www.nasdaq.com/market-activity/stocks/nrxp/sec-filings](https://www.nasdaq.com/market-activity/stocks/nrxp/sec-filings)
I am optimistic about NRXP, but what do you think about the form 8-k that was filed with the SEC on 8/15?
Lots of small fry tickers here. $NRXP has by far the quickest/biggest potential of all of them.
How’s everyone feeling about MBOT obviously we’re still waiting for fda approval i’ve got only about 200 shares but still pretty invested into it. Guys thing approval is soon? Also how’s everyone feeling about NRXP with earnings coming up next week.
So this week is a big week for NRXP
Soo I’ve been rolling through Reddit and it sounds like people have been waiting a while for NRXP. I mean the projections are fantastic but it just sounds like people have been waiting a while
How long of a hold do you think NRXP is?
Agreed on NRXP. If the stars align this thing will 20x
UNCY and NRXP have small MCs and will 10x. UNCY got a clean Complete Response Letter (CRL) from the FDA except for needing to fix a third party manufacturing contractor issue. Meeting with FDA and after 30 day written report of the meeting by FDA (here in Q3), will get a new PDUFA date set. Their drug lowers the number of pills a dialysis patient must take by up to 4 times. 79% of the patients in the trial preferred their drug. NRXP is readying for a pretty amazing setup. It is my favorite bc they address a national health crisis. I made a detailed post earlier this week (where they recd Fast Track designation for NRX-100 and posted on the same day an article stated that Wall Street was beginning to take notice).
We still excited for this week coming up? NRXP - NVNI - BTAI - THTX - CGTX - PSTV 🚀
Still worth investing in either PGEN or CGTX? Got ~700 bucks. Unsure of whether to just get some more of NRXP and MBOT, or even jump in BTAI. Unfortunately I miss the train at times because I am from downunder 😭 and I usually have skeptisism with biotech.
I’m seeing NRXP being brought up a lot any particular reason?
NRXP really wants to break through $3 resistance.
Are we still hopeful on AERT, BTAI, and NRXP? 🚀
NRXP earnings are next week. Love me some r/pennystocks
Thoughts on NRXP? Thinking of holding over the weekend
Haven’t had a terrible day, I jumped on PEGN wagon and got on at 3, so I’m still green, haven’t cashed out on that, not sure what to do. But I did manage to get out of 4 other positions that I’ve been sat on for a while waiting to get out even on. So all in all, happy. Probably holding NRXP, ENLV and PEGN over the weekend unless they have some kind of wild AH swing.
If you got into PGEN early congrats…now do yourselves a favor and look into NRXP.
maybe not cgtx… BUT NRXP HERE WE GO
NRXP starting to move. We loading up now for the coming run?
Just bought some more $NRXP ready for next week 🚀🚀🚀
Interesting. Been watching NRXP for almost a year.
Wish someone told NRXP that then because I got in when their FDA approval came out last week and it went down
$NRXP analyst PT of $21. Currently trading at $2.61. Huge institutional buys during aftermarket and postponed earnings until next week. Expecting news any day now and I’m almost certain this a multi bagger. One to watch as this thing could absolutely fly. After my $CGTX, $IXHL and $NVNI successes I’ve gone all in on this one - then taking a break for the rest of the year. GLTA!
Also watching NRXP, has a PT of $21
$NRXP huge blocks are being bought after hours. Funds orders aren’t being executed until the market closes so something big is brewing. I am very excited for this one
Wish I bought more NRXP might pick up some more tomorrow
$NRXP so excited about this ticker. She is going to fly!
Bought 50 options contracts as well as some shares for NRXP… seeing a lot of ppl saying it should pop any day - this a good play?!
Thank you. I had stated it in my post but apparently in cut and paste from the earnings announcement, I removed it. When they send the Type A meeting results in the next 45 days, I plan to make a more comprehensive post (like my post on NRXP yesterday).
My options for tomorrow are NRXP, ENLV, ADD, and CGTX. I can only pick one
Which date is important for NRXP next week?
Just picked up $1000 of NRXP
Following $CGTX and $IXHL - I really do think $NRXP is going to be the next multi bagger. FDA news could drop any day now and some of the analyst predictions are absolutely insane.
$NRXP potential 20x bagger LFG 🚀🚀🚀🚀🚀🚀
Looks like some good news for NRXP: https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-subsidiary-160000383.html
Just come out of $CGTX with a tidy sum and gone all in with $NRXP. May the stock gods keep smiling on me! GLTA!
[NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025](https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-220600286.html). Was scheduled for today. Was up 10% on the news.
Do we think these will still do well in the next week ? BTAI - NRXP - THTX - XPON - TNYA - WWR
$NRXP have a sneaking suspicion this will run big today. DD on the group - incredible product
$NRXP looks very exciting tbh potential multi bagger with short term catalysts on the horizon
NRXP - BTAI - THTX - XPON - TNYA - CGTX - NVNI - PSTV - TNFA hoping the next week or two will be great 🚀
NRx Pharmaceuticals (NRxP) -- This one is LIVE! Analysts just upgraded their targets to $21 and $31 based on Fast Track granted by FDA this week. Has two drugs that address the national crisis of suicidal ideation in depression, including bipolar depression. Aiming for PDUFA/approval in 2025. **WALL STREET TAKING NOTICE:** As I was writing this post today, this article was just posted on ETrade (VERY TIMELY): [From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street | FinancialContent](https://markets.financialcontent.com/stocks/article/thenewswire-2025-8-13-from-novel-therapies-to-treat-suicidal-bipolar-depression-to-launching-a-network-of-clinics-nrx-pharmaceuticals-is-getting-attention-on-wall-street) If you are looking for the opportunity for the real potential of a 9x to 13x bagger (per the analysts' newly updated targets), NRx is a great candidate based on the below list of facts. If you want to consider investing in NRXP you will need to take the time to read this post. I have tried to make it as concise as possible and give you the full picture. I bought 10,000 shares yesterday at $2.40. The stars are now aligning fast for NRx (note the very current milestone dates below), which has been quietly preparing to **dominate in the depression/suicidality space** with its two drug candidates. * **NRX-100**: **preservative-free** intravenous (IV) **ketamine** infusion, to treat suicidal ideation in patients with depression, including bipolar depression * Rapid and statistically significant reduction in suicidal ideation * **Eliminates** benzethonium chloride **(BZT), a neurotoxic preservative** found in most ketamine products * 3-year room-temperature shelf life (military can use without cold-chain logistics) * Originally granted Fast Track Designation by the FDA in 2017, was only for bipolar depression * **Aug 11 NEWS:** Granted **expanded Fast Track Designation** by the FDA, **increasing the addressable patient population by 10x to 13 million U.S. adults** * [New to The Street Client NRx Pharmaceuticals (NASDAQ:NRXP) Secures ... 2025-08-11](https://www.pr-inside.com/new-to-the-street-client-nrx-pharmaceuticals-nasdaq-nrxp-secures-r5126710.htm) * Reflects FDA's recognition that NRX-100 aligns with eligibility for Accelerated Approval and **CNPV** (see FDA section below) * Initial **NDA filed on Dec 20, 2024**, which included Module 3 (manufacturing), with remaining sections to be completed by **June 2025** * Filed an **ANDA (abbreviated NDA)** with the FDA, for NRX-100, on **June 5, 2025** * Targets all existing approved indications of ketamine, such as anesthesia and pain management * **NRX-101: oral (pill)** fixed-dose combination of D-cycloserine and lurasidone, to treat: * Suicidal bipolar depression, esp. in patients who are treatment resistant * Akathisia, a severe side effect of some antipsychotics linked to increased suicide risk * Industry-leading 75% reduction in Akathisia * Designed as a step-down therapy after IV ketamine to help sustain remission (33% improvement) * Granted **Breakthrough Therapy Designation** by the FDA * **NDA preparation in progress as of March 2025** **FDA CNPV Program** * NRx has applied for the new FDA **Commissioner's National Priority Voucher (CNPV) program** \[**reduces FDA review time to 1 - 2 months**\] , because **NRX-100** meets its criteria (only one of which is required): addresses a national health crisis, addresses unmet public health needs, domestic drug manufacturing for national security * **Watch for an announcement at any time**: If and when the CNPV is granted, then a potential approval decision will be imminent **Manufacturing** * NRX-100 is **manufactured** in collaboration with **Nephron Pharmaceuticals, a well established FDA-approved sterile manufacturing facility** located in West Columbia, South Carolina **Potential Game Changer** * NRx filed a **Citizen Petition** with the FDA, **on Aug 4, 2025**: * **Seeking removal of the neurotoxic preservative BZT from all ketamine products sold in the U.S.** * Could force reformulation or withdrawal of BZT-containing products * Could create a first-mover advantage * Aligns with the FDA's broader push to eliminate toxic excipients **NRx's Dual Strategy** * Provide the drug treatments and roll up interventional psychiatry clinics across the U.S., which will deliver the treatments (also for PTSD, e.g., for veterans and first responders) * **Hope Therapeutics** is a wholly owned subsidiary of NRx. Best I could find is they have approximately 10 or 11 clinics, counting the 2 in Florida that are in the process of closing and which just received approval from Florida's AHCA on **Aug 8, 2025** * Initial goal by end of 2025 is $100M in revenue, as stated in Jan 2025 **ANALYST TARGETS (effective Aug 11, 2025)** * **BTIG: From $18 to $21** [NRx Pharmaceuticals stock price target raised to $21 by BTIG on FDA progress By Investing.com](https://www.investing.com/news/analyst-ratings/nrx-pharmaceuticals-stock-price-target-raised-to-21-by-btig-on-fda-progress-93CH-4183497) * **D. Boral:** **$31** **SHARES** * Outstanding 19.5M (Fintel) * Public Float 16.17M (Fintel) * MC $49M (ETrade) * Short Shares 614,859 (as of 7/31/2025 nasdaq.com) * Inside Ownership 15.9% (Fintel) * Institutional Ownership 13.2% (Fintel) **FINANCES** (Update for Q2 2025, s/b tomorrow 8/14 with Earnings Report and Call) * COH: $6M as of Mar 31, 2025 * Quarterly Burn Rate: $2M est. * Long-Term Debit: $10.3M (financing clinic acquisitions via debt, so they are non-dilutive) * Pre-Revenue as of March 31, 2025 * Convertible note and equity offering in Jan 2025 **MILESTONE PAYMENT AGREEMENTS** * **For NRX-100** * Partner: Undisclosed pharma company (non-binding terms accepted) * Milestone Potential: Over $300M in development and sales milestones * Royalties: Tiered double-digit royalties based on net sales * Status: Terms accepted; agreement not yet finalized * Source: NRx Corporate Update - March 17, 2025 * **For NRX-101** * Partner: Alvogen and Lotus Pharmaceutical * Initial Payment: $5M on Feb 12, 2024 * Positive P2 Meeting: $4M * Milestone Potential: Up to $324M in development and sales milestones * Royalties: Tiered double-digit, escalating to the mid teen on net sales
I didn’t write this. It’s a copy and paste. Also, huge article in Wall Street journal about this company this morning. NRx Pharmaceuticals (NRxP) -- This one is LIVE! Analysts just upgraded their targets to $21 and $31 based on Fast Track granted by FDA this week. Has two drugs that address the national crisis of suicidal ideation in depression, including bipolar depression. Aiming for PDUFA/approval in 2025. **WALL STREET TAKING NOTICE:** As I was writing this post today, this article was just posted on ETrade (VERY TIMELY): [From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street | FinancialContent](https://markets.financialcontent.com/stocks/article/thenewswire-2025-8-13-from-novel-therapies-to-treat-suicidal-bipolar-depression-to-launching-a-network-of-clinics-nrx-pharmaceuticals-is-getting-attention-on-wall-street) If you are looking for the opportunity for the real potential of a 9x to 13x bagger (per the analysts' newly updated targets), NRx is a great candidate based on the below list of facts. If you want to consider investing in NRXP you will need to take the time to read this post. I have tried to make it as concise as possible and give you the full picture. I bought 10,000 shares yesterday at $2.40. The stars are now aligning fast for NRx (note the very current milestone dates below), which has been quietly preparing to **dominate in the depression/suicidality space** with its two drug candidates. * **NRX-100**: **preservative-free** intravenous (IV) **ketamine** infusion, to treat suicidal ideation in patients with depression, including bipolar depression * Rapid and statistically significant reduction in suicidal ideation * **Eliminates** benzethonium chloride **(BZT), a neurotoxic preservative** found in most ketamine products * 3-year room-temperature shelf life (military can use without cold-chain logistics) * Originally granted Fast Track Designation by the FDA in 2017, was only for bipolar depression * **Aug 11 NEWS:** Granted **expanded Fast Track Designation** by the FDA, **increasing the addressable patient population by 10x to 13 million U.S. adults** * [New to The Street Client NRx Pharmaceuticals (NASDAQ:NRXP) Secures ... 2025-08-11](https://www.pr-inside.com/new-to-the-street-client-nrx-pharmaceuticals-nasdaq-nrxp-secures-r5126710.htm) * Reflects FDA's recognition that NRX-100 aligns with eligibility for Accelerated Approval and **CNPV** (see FDA section below) * Initial **NDA filed on Dec 20, 2024**, which included Module 3 (manufacturing), with remaining sections to be completed by **June 2025** * Filed an **ANDA (abbreviated NDA)** with the FDA, for NRX-100, on **June 5, 2025** * Targets all existing approved indications of ketamine, such as anesthesia and pain management * **NRX-101: oral (pill)** fixed-dose combination of D-cycloserine and lurasidone, to treat: * Suicidal bipolar depression, esp. in patients who are treatment resistant * Akathisia, a severe side effect of some antipsychotics linked to increased suicide risk * Industry-leading 75% reduction in Akathisia * Designed as a step-down therapy after IV ketamine to help sustain remission (33% improvement) * Granted **Breakthrough Therapy Designation** by the FDA * **NDA preparation in progress as of March 2025** **FDA CNPV Program** * NRx has applied for the new FDA **Commissioner's National Priority Voucher (CNPV) program** \[**reduces FDA review time to 1 - 2 months**\] , because **NRX-100** meets its criteria (only one of which is required): addresses a national health crisis, addresses unmet public health needs, domestic drug manufacturing for national security * **Watch for an announcement at any time**: If and when the CNPV is granted, then a potential approval decision will be imminent **Manufacturing** * NRX-100 is **manufactured** in collaboration with **Nephron Pharmaceuticals, a well established FDA-approved sterile manufacturing facility** located in West Columbia, South Carolina **Potential Game Changer** * NRx filed a **Citizen Petition** with the FDA, **on Aug 4, 2025**: * **Seeking removal of the neurotoxic preservative BZT from all ketamine products sold in the U.S.** * Could force reformulation or withdrawal of BZT-containing products * Could create a first-mover advantage * Aligns with the FDA's broader push to eliminate toxic excipients **NRx's Dual Strategy** * Provide the drug treatments and roll up interventional psychiatry clinics across the U.S., which will deliver the treatments (also for PTSD, e.g., for veterans and first responders) * **Hope Therapeutics** is a wholly owned subsidiary of NRx. Best I could find is they have approximately 10 or 11 clinics, counting the 2 in Florida that are in the process of closing and which just received approval from Florida's AHCA on **Aug 8, 2025** * Initial goal by end of 2025 is $100M in revenue, as stated in Jan 2025 **ANALYST TARGETS (effective Aug 11, 2025)** * **BTIG: From $18 to $21** [NRx Pharmaceuticals stock price target raised to $21 by BTIG on FDA progress By Investing.com](https://www.investing.com/news/analyst-ratings/nrx-pharmaceuticals-stock-price-target-raised-to-21-by-btig-on-fda-progress-93CH-4183497) * **D. Boral:** **$31** **SHARES** * Outstanding 19.5M (Fintel) * Public Float 16.17M (Fintel) * MC $49M (ETrade) * Short Shares 614,859 (as of 7/31/2025 nasdaq.com) * Inside Ownership 15.9% (Fintel) * Institutional Ownership 13.2% (Fintel) **FINANCES** (Update for Q2 2025, s/b tomorrow 8/14 with Earnings Report and Call) * COH: $6M as of Mar 31, 2025 * Quarterly Burn Rate: $2M est. * Long-Term Debit: $10.3M (financing clinic acquisitions via debt, so they are non-dilutive) * Pre-Revenue as of March 31, 2025 * Convertible note and equity offering in Jan 2025 **MILESTONE PAYMENT AGREEMENTS** * **For NRX-100** * Partner: Undisclosed pharma company (non-binding terms accepted) * Milestone Potential: Over $300M in development and sales milestones * Royalties: Tiered double-digit royalties based on net sales * Status: Terms accepted; agreement not yet finalized * Source: NRx Corporate Update - March 17, 2025 * **For NRX-101** * Partner: Alvogen and Lotus Pharmaceutical * Initial Payment: $5M on Feb 12, 2024 * Positive P2 Meeting: $4M * Milestone Potential: Up to $324M in development and sales milestones * Royalties: Tiered double-digit, escalating to the mid teen on net sales
NRXP? Wondering if this is a real play?
Huge things happening with NRXP…. Huge things!!!
Huge over night plays for me tonight! Up huge today thanks to IPO. My plays NRXP and PAVM. Fingers crossed
The only FDA approved ketamine is Spravato nasal spray (Esketamine), for treatment resistant depression and MDD suicidaltiy. It contains a different preservative than BZT. All others are off label—not FDA approved, from what AI tells me. Some or maybe many contain BZT. I believe the FDA will have no problem at all ruling that ketamine with BZT cannot be used any longer and would probably have to give an effective date in order to allow the transition to NRX-100. Other companies will have to reformulate to preservative-free and that will take time. Plus they will need to submit to the FDA because I don’t see the FDA allowing off-label usage once an FDA approved drug is available. My opinion, but only makes sense or why go through the review and approval process. If granted, the Citizen Petition approval will be amazing for NRXP. I need to go back and edit or save for another post, but if you havent already, check out the Chairman’s experience (worked under 4 presidents).
NRXP $3.25 this month? Absolute pipe dream?
I haven’t sold a single share of NRXP. I still think it’s a great buy. All I have to say is time will tell.
NRXP hopefully will get FDA approval by EOY
Whoever brought $NRXP to my attention. Much appreciated!
FWIW, SEC filings say that the expected PDUFA date for both drug candidates, NRX-100 and NRX-101, is the end of 2025. Ref.: 10-Q for 25Q1 (https://www.sec.gov/edgar/search/#/ciks=0001719406&entityName=NRX%2520Pharmaceuticals%252C%2520Inc.%2520(NRXP%252C%2520NRXPW)%2520(CIK%25200001719406)
From Stocktwits: @AIIAAIIA_88 They submitted the first module of the NDA for NRX-100 under Rolling Review in December, so FDA catalyst calendars got confused. We’re expecting the rest of that NDA and the NDA for NRX-101 shortly (and NRXP is close to closing on its first profitable leading interventional psychiatry clinics). This will definitely impact price positively if all goes well
So far today. I have not really done many plays. Bought some PYPD - sold for a loss cause am dumb. Now I am sitting on 1 share of OMH, SOGP, KNW, NRXP and 50 shares of KLTO and basically just letting all of them ride till market open then putting a 20% TSL on them all. Might make actual plays later but these are just fun for now Other than that. Hope you all get out with a green day today and I post again in about 1.5 hours stating the IPOs - if there are any Have a fun day all
Riding NRXP until this horse stops. But there’s catalyst after catalyst dropping lately. Not only is there approval coming up, but they’re getting financing and adding clinics for current revenue as well. Fingers crossed. Good luck to all.
Plays I'm looking at for tomorrow: INTZ NCL AUUD NRXP CYCU NFA, I'm a newb and don't know what I'm doing
NRXP, Been riding this one for a month, and cashing in everyday. It may be about to go into orbit……
NRXP - I believe they will eventually get drug approval from the FDA ( PDUFA due this month ) and acquire the clinics they have been speaking about....It's just taking longer than most investors would like....
PDUFA date for $NRXP is June, 30th. There will be no surprises if it skyrocket.
There's an actual ketamine pure play if you really want it, NRXP. Still waiting on FDA approval but should be a shoe in